Source: Anais eletrônicos. Conference titles: Brazilian Symposium on Medicinal Chemistry - BrazMedChem. Unidade: IFSC
Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, PLANEJAMENTO DE FÁRMACOS
ABNT
REZENDE JUNIOR, Celso et al. Carbamoylimidazoles as potent cruzain inhibitors with in vitro and in vivo trypanocidal activity: a structure-based drug design approach. 2019, Anais.. Campinas: Galoá, 2019. Disponível em: https://proceedings.science/p/107156. Acesso em: 01 nov. 2024.APA
Rezende Junior, C., Souza, M. L., Chavez, R., Ferreira, R. S., Slafer, B. W., Cruz, F. C., et al. (2019). Carbamoylimidazoles as potent cruzain inhibitors with in vitro and in vivo trypanocidal activity: a structure-based drug design approach. In Anais eletrônicos. Campinas: Galoá. Recuperado de https://proceedings.science/p/107156NLM
Rezende Junior C, Souza ML, Chavez R, Ferreira RS, Slafer BW, Cruz FC, Ferreira LLG, Magalhães LG, Andricopulo RK, Oliva G, Andricopulo AD, Dias LC. Carbamoylimidazoles as potent cruzain inhibitors with in vitro and in vivo trypanocidal activity: a structure-based drug design approach [Internet]. Anais eletrônicos. 2019 ;[citado 2024 nov. 01 ] Available from: https://proceedings.science/p/107156Vancouver
Rezende Junior C, Souza ML, Chavez R, Ferreira RS, Slafer BW, Cruz FC, Ferreira LLG, Magalhães LG, Andricopulo RK, Oliva G, Andricopulo AD, Dias LC. Carbamoylimidazoles as potent cruzain inhibitors with in vitro and in vivo trypanocidal activity: a structure-based drug design approach [Internet]. Anais eletrônicos. 2019 ;[citado 2024 nov. 01 ] Available from: https://proceedings.science/p/107156